Education
About Us
Working with TipRanks
Follow Us
Baxter International (DE:BTL)
FRANKFURT:BTL
Earnings Data
Report Date
Jul 24, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.54Last Year’s EPS
0.6Same Quarter Last Year
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 01, 2025
|% Change Since: -10.84%
|Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment|Positive
Baxter International reported strong first quarter results, surpassing guidance with significant growth in all segments and improved earnings per share. However, the company is facing challenges due to tariffs and foreign exchange impacts, which could affect future performance. Despite these challenges, the company maintains a positive outlook based on strong operational performance and strategic initiatives.Company Guidance
During Baxter International's first quarter 2025 earnings conference call, the company exceeded its previously issued guidance with a 5% growth in sales from continuing operations, totaling $2.3 billion. The adjusted earnings per share from continuing operations were reported at $0.55, surpassing expectations. The Medical Products & Therapies (MPT) segment saw a 6% sales increase, with notable contributions from the Infusion Therapies & Technologies division. Healthcare Systems and Technologies (HST) sales rose 6%, led by a 7% growth in the Care and Connectivity Solutions division. Pharmaceuticals segment sales grew by 3%, with a 4% increase in injectables and anesthesia sales. The company is addressing challenges such as newly enacted global tariffs, estimating a $60 million to $70 million impact for the year, and is implementing mitigation strategies. Baxter expects full-year 2025 sales growth of 7% to 8% on a reported basis, maintaining its operational growth forecast of 4% to 5%. The company is focused on accelerating sales growth, expanding margins, and optimizing its supply chain amid the global macroeconomic environment.Exceeded Guidance in Q1 2025
First quarter performance for continuing operations exceeded previously issued guidance on both the top and bottom lines, with sales growing 5% on a reported and operational basis.
Positive Segment Growth
Sales rose in all three of Baxter's continuing segments, with Medical Products & Therapies and Healthcare Systems and Technologies performing ahead of expectations.
Strong Performance in Healthcare Systems and Technologies
HST segment sales totaled $704 million, increasing 6%, with a strong order backlog and competitive account wins, particularly in Care and Connectivity Solutions.
Improved Earnings Per Share
Adjusted earnings per share from continuing operations were $0.55, driven by top-line performance and operational efficiency.
Successful Recovery from Hurricane Impact
Production at the North Cove IV solutions facility returned to pre-hurricane levels, and the company expects to be off virtually all product allocations soon.
DE:BTL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:BTL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 20, 2025 | €29.45 | €31.20 | +5.91% |
Nov 08, 2024 | €32.75 | €32.91 | +0.47% |
Aug 06, 2024 | €29.77 | €31.31 | +5.20% |
May 02, 2024 | €36.62 | €36.06 | -1.52% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Baxter International (DE:BTL) report earnings?
Baxter International (DE:BTL) is schdueled to report earning on Jul 24, 2025, TBA Not Confirmed.
What is Baxter International (DE:BTL) earnings time?
Baxter International (DE:BTL) earnings time is at Jul 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Baxter International stock?
The P/E ratio of Baxter International is N/A.
What is DE:BTL EPS forecast?
DE:BTL EPS forecast for the fiscal quarter 2025 (Q2) is 0.54.
